Clomivid review

Clomivid is used for the treatment of infertility among women. It stimulates increased hormones vital to the growth and release of mature eggs for ovulation.

Clomivid is available in pill form and is marketed under the brand names Clomin, Milophene, Serophene, Clomid, Clomiphene, Clomphid, Clostilbegyt, Dyneric, Omifin, and Ikaclomin.

Women having difficulties getting pregnant may take Clomivid. It may be used in tandem with a medicine called Metformin to help patients ovulate and become pregnant.

Studies reveal that 70 % of those who used Clomivid were able to ovulate, a good majority of them during the first months of treatment. Of that population, about 15-50% became pregnant.

Patients are prescribed 50 milligrams of Clomivid for 5 days beginning on the fifth day of their menstrual cycle. In case ovulation does not occur, dosage can be increased to 100 milligrams for 5 days the month after the previous dosage. It is not advised that women take Clomivid after 6 treatment cycles.

Following the dosing schedule is important to get the best results. Patients should not take the pill for longer than the doctor prescribed. In case of a missed dosage, patients should immediately inform their doctor to determine the next steps. It is not recommended that patients take double dosages to resume their dosing schedule.

For best results, physicians may look into some factors, including the body temperature of the patient and ovulation tests prior to prescribing Clomivid.

Patients may experience side effects including upset stomach, hot flashes, pelvic fullness, headache, breast tenderness, or dizziness. If these symptoms persist, patients should immediately notify their physicians. In general, the chances of a patient experiencing these side effects are low.

Patients may experience changes in their vision such as seeing flashes while taking Clomivid. This is more common if they are exposed to intense lighting. If a patient does experience this side effect, it may go away after a couple of days after treatment.

Other serious side effects include vaginal bleeding and changes in moods. Some patients may experience severe pain or swelling in the pelvic area, diarrhea, difficulty in breathing, chest pain, irregular heartbeat, nausea, and swelling of the legs.

Before taking Clomivid, women should inform their doctor about any history of allergies to medications. Patients should also consult their physician about their conditions such as liver illness, vaginal bleeding, uncontrolled thyroid, and pituitary tumor before agreeing to use Clomivid.

There have been cases where the use of Clomivid resulted in the patient having multiple births like twins and triplets.

Women are also advised against engaging in activities that require mental alertness such as driving since Clomivid can make a person dizzy or suffer from blurred vision.

Patients should inform their physicians or pharmacist about all the prescription medicines they are using before taking Clomivid.

Clomivid has the following structural formula:

Chemical structure of clomivid

• Molecular formula of clomivid is C26H28ClNO
• Chemical IUPAC Name is 2-[4-[(Z)-2-chloro-1,2-di(phenyl)ethenyl]phenoxy]-N,N-diethylethanamine
• Molecular weight is 405.9596 g/mol
Clomivid available : 50mg tablets

Generic name: Clomifene

Brand name(s): Androxal, Clomid, Clomifen, Clomifert, Clomiphene, Clomiphene B, Clomphid, Clostilbegyt, Dyneric, Genozym, Ikaclomin, Milophene, Omifin, Serophene

  Your Clomivid review